bisantrene has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angier, RB; Citarella, RV; Durr, FE; Forbes, M; Murdock, KC; Wallace, RE | 1 |
| Coltman, CA; Forseth, B; Von Hoff, DD | 1 |
2 other study(ies) available for bisantrene and Experimental Neoplasms
| Article | Year |
|---|---|
Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
Topics: Animals; Anthracenes; Antineoplastic Agents; Doxorubicin; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Fluorouracil; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Plasmacytoma | 1982 |
Activity of 9-10 anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone]dihydrochloride (CL216,942) in a human tumor cloning system. Leads for phase II trials in man.
Topics: Anthracenes; Antineoplastic Agents; Cells, Cultured; Clone Cells; Colony-Forming Units Assay; Drug Evaluation; Drug Evaluation, Preclinical; Humans; Neoplasms, Experimental | 1981 |